← Eichor
Study identifier: NCT06449534 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effect of the Treatment Environment on Pain, Function, Self Efficacy and Satisfaction in RCRSP

Condition: Shoulder Pain · Subacromial Pain Syndrome · Rotator Cuff Syndrome of Shoulder and Allied Disorders  ·  Sponsor: Istanbul University - Cerrahpasa

PhaseNA
Planned participants34
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Brief Summary The aim of this randomized controlled study is to reveal the short-term effects of physical and social factors in different therapeutic environments on patients with rotator cuff related shoulder pain following the same exercise program. The main questions it aims answer are: * Is there any difference in terms of pain levels among groups with rotator cuff related shoulder pain who treated in different therapeutic settings. * Is there any difference in terms of functionality and self-efficacy among groups with rotator cuff related shoulder pain who treated in different therapeutic settings.

This description comes directly from the study's public registry record.

Talk to the study team

Merve KOYUNCU CENİKLİ, Research asistant  ·  5459039585  ·  merve.cenikli@iuc.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

İstanbul University Cerrahpasa Faculty of Health SciencesIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06449534